Rockwell Medical Inc RMTI Fundamentals and Key Ratios

Rockwell Medical Inc. (RMTI) Fundamentals


Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell Medical is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell Medical is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.

SHARE INFORMATION
Market Cap	$ 15,471,455
Shares Outstanding	11,632,673
Float	10,153,068
Percent Float	87.28%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 61,930,000
Latest Fiscal EPS	$ -3.85
Latest Fiscal Date	2021-12-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	-

HOLDERS
Institutions	65
Institutional Holdings Date	2023-02-28
Institutional Bought Previous 3 Months	332,372
Institutional Holdings Percent	29.9%
Institutional Sold Previous 3 Months	137,898
Insider Holdings Date	2023-02-28
Insider Bought Previous 3 Months	-
Insider Holdings Percent	61.5
Insider Sold Previous 3 Months	-
Insider Shares Owned	7,156,780

TRADING INFO
52 Week High	$ 5.50
52 Week Low	$ 0.84
52 Week High Change	$ -69.00
21 Day Moving Average	$ 1.5824
21 Day Extended Moving Average	$ 1.5506
50 Day Moving Average	$ 1.8047
50 Day Extended Moving Average	$ 1.623
200 Day Moving Average	$ 1.4272
200 Day Extended Moving Average	$ 1.9676
10 Day Average Volume	101,973
20 Day Average Volume	129,740
30 Day Average Volume	226,052
50 Day Average Volume	356,564
Alpha	-0.047516
Beta	1.1834
Standard Deviation	0.203860
R2	0.097718
7 Day Price Change	$ 0.05
7 Day Percent Change	3.91%
21 Day Price Change	$ -0.29
21 Day Percent Change	-17.9%
30 Day Price Change	$ -0.91
30 Day Percent Change	-40.63%
Month to Date Price Change	$ -0.31
Month to Date Percent Change	-18.9%
Quarter to Date Price Change	$ 0.315
Quarter to Date Percent Change	31.03%
180 Day Price Change	$ -0.005
180 Day Percent Change	-0.37%
200 Day Price Change	$ -0.36
200 Day Percent Change	-21.3%
Year to Date Price Change	$ 0.315
Year to Date Percent Change	31.03%

PROFITABILITY
EBIT Margin	-33.7%
EBITDA Margin	-29.9%
Pre-Tax Profit Margin	-56.0%
Profit Margin Count	-30.5%
Gross Margin	-0.7%
Profit Margin TOT	-30.5%

INCOME STATEMENTS
Revenue	$ 53,497,000
Revenue Per Share	$ 4.5989
Revenue (3 Years)	$ -2.99
Revenue (5 Years)	$ -0.47

FINANCIAL STRENGTH
Price to Tangible Book	1.10
Total Debt To Equity	1.40
Int Coverage	-11.10
Current Ratio	2.20
Leverage Ratio	4.60
Quick Ratio	1.80
Long Term Debt To Capital	0.47

VALUATION MEASURES
PE Ratio	-0.70
Enterprise Value	$ 10,751,088
Price to Sales	0.289202
Price to Free Cash	-0.90
PE High Last 5 Years	-4.80
Price To Book	1.00
Price To Cash Flow	76.10
PE Low Last 5 Years	-12.70
Price to Tangible Book	1.10

MANAGEMENT EFFECTIVENESS
Receivables Turnover	8.60
Invoice Turnover	16.20
Assets Turnover	1.10
Return Assets	-48.61
Return on Equity	-197.84
Return on Capital	-58.58

PROFILE INFO
Issue Type	CS
SEC Type	EQS
Auditor	Marcum LLP
CEO	Mark Strobeck
Emplyoees	300
Last Audit	UQ
CIK	0001041024
Industry	Drug Manufacturers
Sector	Healthcare
NAICS	Pharmaceutical Preparation Manufacturing(325412)

CONTACT INFO
Address	30142 Wixom Road Suite 501 Wixom, MI 48393
Website	https://www.rockwellmed.com
Facsimile	+1 248 960-9119
Telephone	+1 800 449-3353
Email	IR@rockwellmed.com

Boards:

Quotes:

RMTI